Shots: The P-III KEYNOTE-048 study results involves assessing of Keytruda + CT (carboplatin/cisplatin + 5-FU) and Keytruda as monothx. vs EXTREME regimen in 882 patients with recurrent or metastatic HNSCC, […]readmore
Tags : KEYNOTE-048